Clinical Trial Update: Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old) [Phase 2]

View source ↗

Summary

Phase 2 multicenter study evaluating risk-adapted treatment for T-lineage/ T-cell adult acute lymphoblastic leukemia in young adults (18-59).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: T-cell Adult Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN